The University of Siena PhD Course in
Genetics, Oncology and Clinical Medicine
Genetics, Oncology and Clinical Medicine
PhD Graduate

PhD Program years: 2012 - 2015
PUBLICATIONS DURING THE PHD PROGRAM
1. Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
Di Giacomo AM, Calabrò L, Danielli R, Fonsatti E, Bertocci E, Pesce I, Fazio C, Cutaia O, Giannarelli D, Miracco C, Biagioli M, Altomonte M, Maio M.
Cancer Immunol Immunother. 2013 Jun.
2. Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.
Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Parisi G, Cutaia O, Fonsatti E, Parmiani G.
Cancer Immunol Immunother. 2013 Nov.
3. Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.
Calabrò L, Morra A, Fonsatti E, Cutaia O, Amato G, Giannarelli D, Di Giacomo AM, Danielli R, Altomonte M, Mutti L, Maio M.Lancet Oncol. 2013 Oct.
ABSTRACTS OF CONFERENCE DURING THE PHD PROGRAM
ACTIVITY DURING THE PHD PROGRAM
TRAINING PERIOD ABROAD
-
Hosting Institution Name
Location
Period dates
-
Hosting Institution Name
Location
Period dates